Literature DB >> 26377313

Microenvironment in metastasis: roadblocks and supportive niches.

Maren Pein1, Thordur Oskarsson2.   

Abstract

In many cancers, malignant cells can spread from the primary tumor through blood circulation and initiate metastasis in secondary organs. Metastatic colonization may depend not only on inherent properties of cancer cells, but also on suitable microenvironments in distant sites. Increasing evidence suggests that the nature of the microenvironment may determine the fate of disseminated cancer cells, providing either hindrance or support for cancer cell propagation. This can result in strong selective pressure where the vast majority of cancer cells, invading a secondary organ, are either eliminated or maintained in a dormant state. The ability of cancer cells to fend off or circumvent anti-metastatic signals from the stroma and the capacity to manipulate the local microenvironment towards a supporting environment, a metastatic niche, may be essential for metastatic growth. The molecular interactions between cancer cells and the stroma are still enigmatic, but recent studies are beginning to reveal their nature. Here, we discuss the interactive relationship between metastatic cancer cells and host stroma, involving selection and adaptation of metastasis-initiating cells and host tissue remodeling. Understanding the dynamic and continuously evolving cross talk between metastatic cancer cells and the stroma may be crucial when developing cancer treatments.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  cancer; metastasis; microenvironment; niche; stem cells

Mesh:

Year:  2015        PMID: 26377313     DOI: 10.1152/ajpcell.00145.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  22 in total

1.  Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.

Authors:  Maria E Gonzalez; Emily E Martin; Talha Anwar; Caroline Arellano-Garcia; Natasha Medhora; Arjun Lama; Yu-Chih Chen; Kevin S Tanager; Euisik Yoon; Kelley M Kidwell; Chunxi Ge; Renny T Franceschi; Celina G Kleer
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

2.  Maintaining unperturbed cerebral blood flow is key in the study of brain metastasis and its interactions with stress and inflammatory responses.

Authors:  Amit Benbenishty; Niva Segev-Amzaleg; Lee Shaashua; Rivka Melamed; Shamgar Ben-Eliyahu; Pablo Blinder
Journal:  Brain Behav Immun       Date:  2017-02-20       Impact factor: 7.217

3.  Low-molecular-weight hyaluronan (LMW-HA) accelerates lymph node metastasis of melanoma cells by inducing disruption of lymphatic intercellular adhesion.

Authors:  Yan Du; Manlin Cao; Yiwen Liu; Yiqing He; Cuixia Yang; Man Wu; Guoliang Zhang; Feng Gao
Journal:  Oncoimmunology       Date:  2016-09-09       Impact factor: 8.110

Review 4.  Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.

Authors:  L Farahmand; B Darvishi; K Majidzadeh-A; A Madjid Ansari
Journal:  Cell Prolif       Date:  2016-09-27       Impact factor: 6.831

5.  Dual roles of CCN proteins in breast cancer progression.

Authors:  Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2016-08-12       Impact factor: 5.782

6.  Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.

Authors:  Mehboob Ali; Kathryn Heyob; Naduparambil K Jacob; Lynette K Rogers
Journal:  Mol Cancer Ther       Date:  2016-08-05       Impact factor: 6.261

7.  Losses of cytokines and chemokines are common genetic features of human cancers: the somatic copy number alterations are correlated with patient prognoses and therapeutic resistance.

Authors:  Henry Sung-Ching Wong; Wei-Chiao Chang
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110

8.  Targeting metastasis-initiating cells through the fatty acid receptor CD36.

Authors:  Gloria Pascual; Alexandra Avgustinova; Stefania Mejetta; Mercè Martín; Andrés Castellanos; Camille Stephan-Otto Attolini; Antoni Berenguer; Neus Prats; Agustí Toll; Juan Antonio Hueto; Coro Bescós; Luciano Di Croce; Salvador Aznar Benitah
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

9.  Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition.

Authors:  Nezihi Murat Karabacak; Yu Zheng; Taronish D Dubash; Risa Burr; Douglas S Micalizzi; Ben S Wittner; Maoxuan Lin; Devon F Wiley; Valentine Comaills; Erin Emmons; Kira L Niederhoffer; Uyen Ho; Jacob Ukleja; Dante Che; Hannah Stowe; Linda T Nieman; Wilhelm Haas; Shannon L Stott; Michael S Lawrence; David T Ting; David T Miyamoto; Daniel A Haber; Mehmet Toner; Shyamala Maheswaran
Journal:  Cancer Res       Date:  2022-03-15       Impact factor: 13.312

Review 10.  Heterogeneity within molecular subtypes of breast cancer.

Authors:  Kevin M Turner; Syn Kok Yeo; Tammy M Holm; Elizabeth Shaughnessy; Jun-Lin Guan
Journal:  Am J Physiol Cell Physiol       Date:  2021-06-30       Impact factor: 5.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.